Prilenia
Prilenia is a clinical-stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders.
Org chart
Collapse
Henk Schuring
Chief Regulatory & Commercialization Officer
Y Paul Goldberg
Chief Scientific Officer & Head of Early Development
Anne Sullivan
Chief Business Officer
Terese Hoekstra
VP & Head of Global Market Access
Nancy Ortiz
VP & Head of Medical Affairs
Gail Hartigan
VP, U.S Sales
Yael Cohen
Head of Clinical Operations
Elena Berelovich
Head of CMC
Osnat Ram Shoham
Head of Finance
Michal Geva
Head of Research
Kristina Coppola
Head of Corporate Communications
Irina Elkin
Senior Director, Commercial Operations & Analytics
Leehee Navon-Perry
Director, Medical Writing
Irene Darras
Director of Regulatory Affairs
Randal Hand
Director of Neuroscience Research
Kelly Chen
Director of Biostatistics
Andres Cruz-Herranz
Director of Clinical Development
Elizabeth Consigli
Associate Director, CMC Analytical Development
Seth Rotberg
Senior Manager, Patient Advocacy & Engagement
Christine DiTondo
Senior Manager of Business Development
Mira Firoz
Executive Assistant & Office Manager
Rachel Razzaghi
Executive Assistant, North America
Teams
View all
Discover similar companies
MOMA Therapeutics
Series B • Cambridge, United States
Synthekine
Series B • Menlo Park, United States
Expansion Therapeutics
Series B • San Diego, United States
Q32 Bio
Series B • Cambridge, United States
Salto
Series B • Tel Aviv-Yafo, Israel
Komodor
Series B • Tel Aviv-Yafo, Israel
Obsidian Therapeutics
Series B • Cambridge, United States
Brightseed
Series B • San Francisco, United States
Aspen Neuroscience
Series B • San Diego, United States
Cue Biopharma
Series B • Cambridge, United States
Kadimastem
Post IPO Equity • Ness Ziona, Israel
Fusion Pharmaceuticals
Series B • Hamilton, Canada
The Org
helps you hire
great candidates
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.
It’s free to use - try it out today.